Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has experienced a positive financial outlook, with normalized funds from operations (NFFO) estimates for 2025 rising to $4.80 per share, slightly above the adjusted guidance range of $4.78 to $4.82 per share from management. The company's performance reflects a robust year-over-year growth forecast, projecting a 5.3% increase in normalized FFO per share in 2025 and an additional 4.8% growth anticipated for 2026. Additionally, the upward revision of the 2026 FFO estimate to $5.03 per share, exceeding consensus expectations, further reinforces the company's strong financial trajectory.

Bears say

National Health Investors Inc faces a negative outlook primarily due to the anticipated lower earnings growth over the next few years, which reflects a challenge in balancing accretive acquisition activity with potential operational disruptions. The company's performance could be adversely affected by a lower-than-expected rent reset from National HealthCare Corporation, as well as risks associated with deferred rent collections and operator challenges, which may be exacerbated by ongoing public health concerns. These factors contribute to a cautious view on the company’s financial stability and revenue projections.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.